Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Acq. announced
Quarterly results
Auditor change
Appointed director
CC transcript
Director departure
SEELOS THERAPEUTICS, INC. (APRI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2019 8-K/A Quarterly results
01/30/2019 8-K/A Quarterly results
09/28/2016 8-K/A Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Secu...
Docs: "Legal Opinion of Brownstein Hyatt Farber Schreck, LLP"
07/06/2016 8-K/A Form 8-K/A - Current report [Amend]
01/13/2016 8-K/A Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Opinion of Brownstein Hyatt Farber Schreck, LLP",
"Opinion of Latham & Watkins LLP"
12/11/2012 8-K/A Termination of a Material Definitive Agreement
09/27/2012 8-K/A Form 8-K/A - Current report [Amend]
03/01/2010 8-K/A Form 8-K/A - Current report [Amend]
05/30/2008 8-K/A Form 8-K/A - Current report [Amend]
11/08/2004 8-K/A Form 8-K/A - Current report [Amend]
03/16/1998 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy